EUVIMEDEUVIMED entdecken
Open Access

Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations

Alicja Pacholewska iD, Matthias Lienhard iD, Mirko Brüggemann, Heike Hänel, Lorina Bilalli, Anja Königs, Felix Heß, Kerstin Becker, Karl Köhrer, Jesko Kaiser, Holger Gohlke, Norbert Gattermann und 7 weitere

Genome Research · 2024-11 · 34 (11) · 1832-1848

DOI: 10.1101/gr.279327.124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genome Research, online erschienen am 13.09.2024. Verfasst von Alicja Pacholewska und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Epigenetics, Faculty of Medicine, University of Cologne, 50931 Cologne, Germany. Hauptthemen laut MEDLINE: RNA Splicing Factors, Leukemia, Lymphocytic, Chronic, B-Cell, Myelodysplastic Syndromes, Phosphoproteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Deutsche Forschungsgemeinschaft [DFG, German Research Foundation], DFG Research Infrastructure West German Genome Center, Next Generation Sequencing Competence Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in splicing factor 3B subunit 1 ( SF3B1 ) frequently occur in patients with chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDSs). These mutations have different effects on the disease prognosis with beneficial effect in MDS and worse prognosis in CLL patients. A full-length transcriptome approach can expand our knowledge on SF3B1 mutation effects on RNA splicing and its contribution to patient survival and treatment options. We applied long-read transcriptome sequencing (LRTS) to 44 MDS and CLL patients, as well as two pairs of isogenic cell lines with and without SF3B1 mutations, and found >60% of novel isoforms. Splicing alterations were largely shared between cancer types and specifically affected the usage of introns and 3′ splice sites. Our data highlighted a constrained window at canonical 3′ splice sites in which dynamic splice-site switches occurred in SF3B1 -mutated patients. Using transcriptome-wide RNA-binding maps and molecular dynamics simulations, we showed multimodal SF3B1 binding at 3′ splice sites and predicted reduced RNA binding at the second binding pocket of SF3B1 K700E . Our work presents the hitherto most-complete LRTS study of the SF3B1 mutation in CLL and MDS and provides a resource to study aberrant splicing in cancer. Moreover, we showed that different disease prognosises result most likely from the different cell types expanded during carcinogenesis rather than different mechanisms of action of the mutated SF3B1. These results have important implications for understanding the role of SF3B1 mutations in hematological malignancies and other related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splicing FactorsLeukemia, Lymphocytic, Chronic, B-CellMyelodysplastic SyndromesPhosphoproteinsMutationTranscriptomeHumansRNA SplicingRNA Splice SitesMale

Substanzen

RNA Splicing FactorsSF3B1 protein, humanPhosphoproteinsRNA Splice Sites

Autor:innen und Institutionen

  • Institute for Translational Epigenetics, Faculty of Medicine, University of Cologne, 50931 Cologne, Germany.
  • Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University of Cologne, 50931 Cologne, Germany.
  • Department of Computational Molecular Biology, Max Planck Institute (MPI) for Molecular Genetics, 14195 Berlin, Germany.
  • Buchmann Institute for Molecular Life Sciences and Institute of Molecular Biosciences, Goethe University Frankfurt, 60438 Frankfurt, Germany.
  • Institute of Molecular Biology, 55128 Mainz, Germany.
  • Genomics and Transcriptomics Laboratory, Biological and Medical Research Center, Heinrich Heine University and West German Genome Center, 40225 Düsseldorf, Germany.

ORCID-Profile: Alicja Pacholewska, Matthias Lienhard, Christina Grimm, Kathi Zarnack, Michal R Schweiger

Förderung

  • Deutsche Forschungsgemeinschaft [DFG, German Research Foundation]
  • DFG Research Infrastructure West German Genome Center
  • Next Generation Sequencing Competence Network
  • German Research Foundation
  • Volkswagen Stiftung Lichtenberg program
  • Center for Molecular Medicine Cologne

Zitieren

APA

Pacholewska, A., Lienhard, M., Brüggemann, M., Hänel, H., Bilalli, L., Königs, A., Heß, F., Becker, K., Köhrer, K., Kaiser, J., Gohlke, H., Gattermann, N., Hallek, M., Herling, C. D., König, J., Grimm, C., Herwig, R., Zarnack, K., & Schweiger, M. R. (2024). Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations. Genome Research, 34(11), 1832-1848. https://doi.org/10.1101/gr.279327.124

Vancouver

Pacholewska A, Lienhard M, Brüggemann M, Hänel H, Bilalli L, Königs A, et al. Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations. Genome Research. 2024;34(11):1832-1848. doi:10.1101/gr.279327.124

BibTeX
@article{Pacholewska2024,
  author = {Pacholewska, Alicja and Lienhard, Matthias and Brüggemann, Mirko and Hänel, Heike and Bilalli, Lorina and Königs, Anja and Heß, Felix and Becker, Kerstin and Köhrer, Karl and Kaiser, Jesko and Gohlke, Holger and Gattermann, Norbert and Hallek, Michael and Herling, Carmen D and König, Julian and Grimm, Christina and Herwig, Ralf and Zarnack, Kathi and Schweiger, Michal R},
  title = {Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations},
  journal = {Genome Research},
  year = {2024},
  volume = {34},
  number = {11},
  pages = {1832--1848},
  doi = {10.1101/gr.279327.124}
}
Kostenlos starten →